Literature DB >> 7773633

Myofibroblast differentiation during fibrosis.

A Desmoulière1, G Gabbiani.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1995        PMID： 7773633

Source DB:  PubMed          Journal:  Exp Nephrol        ISSN： 1018-7782


× No keyword cloud information.
  17 in total

Review 1.  Epithelial-mesenchymal transitions and the intersecting cell fate of fibroblasts and metastatic cancer cells.

Authors:  Eric G Neilson; David Plieth; Christo Venkov
Journal:  Trans Am Clin Climatol Assoc       Date:  2003

Review 2.  Morphology of interstitial cells in the healthy kidney.

Authors:  B Kaissling; I Hegyi; J Loffing; M Le Hir
Journal:  Anat Embryol (Berl)       Date:  1996-04

3.  Inhibitory effects of hepatocyte growth factor and interleukin-6 on transforming growth factor-beta1 mediated vocal fold fibroblast-myofibroblast differentiation.

Authors:  Bimal Vyas; Keiko Ishikawa; Suzy Duflo; Xia Chen; Susan L Thibeault
Journal:  Ann Otol Rhinol Laryngol       Date:  2010-05       Impact factor: 1.547

4.  Matrix contraction by dermal fibroblasts requires transforming growth factor-beta/activin-linked kinase 5, heparan sulfate-containing proteoglycans, and MEK/ERK: insights into pathological scarring in chronic fibrotic disease.

Authors:  Yunliang Chen; Xu Shi-Wen; Jonathan van Beek; Laura Kennedy; Marilyn McLeod; Elisabetta A Renzoni; George Bou-Gharios; Sarah Wilcox-Adelman; Paul F Goetinck; Mark Eastwood; Carol M Black; David J Abraham; Andrew Leask
Journal:  Am J Pathol       Date:  2005-12       Impact factor: 4.307

5.  Structural and functional changes in heparan sulfate proteoglycan expression associated with the myofibroblastic phenotype.

Authors:  Gareth Thomas; Aled Clayton; Janet Thomas; Malcolm Davies; Robert Steadman
Journal:  Am J Pathol       Date:  2003-03       Impact factor: 4.307

6.  FAK-related nonkinase is a multifunctional negative regulator of pulmonary fibrosis.

Authors:  Qiang Ding; Guo-Qiang Cai; Meng Hu; Youfeng Yang; Anni Zheng; Qinjiu Tang; Candece L Gladson; Haurko Hayasaka; Hongju Wu; Zhiying You; Brian D Southern; Lisa M Grove; S Ohidar Rahaman; Haotian Fang; Mitchell A Olman
Journal:  Am J Pathol       Date:  2013-03-14       Impact factor: 4.307

7.  Renal fibrosis is attenuated by targeted disruption of KCa3.1 potassium channels.

Authors:  Ivica Grgic; Eva Kiss; Brajesh P Kaistha; Christoph Busch; Michael Kloss; Julia Sautter; Anja Müller; Anuradha Kaistha; Claudia Schmidt; Girija Raman; Heike Wulff; Frank Strutz; Hermann-Josef Gröne; Ralf Köhler; Joachim Hoyer
Journal:  Proc Natl Acad Sci U S A       Date:  2009-08-13       Impact factor: 11.205

Review 8.  The role of the adventitia in vascular inflammation.

Authors:  Kathryn Maiellaro; W Robert Taylor
Journal:  Cardiovasc Res       Date:  2007-06-29       Impact factor: 10.787

9.  Targeting myofibroblasts in model systems of fibrosis by an artificial alpha-smooth muscle-actin promoter hybrid.

Authors:  Julia Hirschfeld; Julia Maurer; Diana Jung; Monika Kwiecinski; Al Karim Khimji; Hans Peter Dienes; Jochen W U Fries; Margarete Odenthal
Journal:  Mol Biotechnol       Date:  2009-06-24       Impact factor: 2.695

10.  Expression of P311, a transforming growth factor beta latency-associated protein-binding protein, in human kidneys with IgA nephropathy.

Authors:  Fengping Wang; Xisheng Xie; Junming Fan; Li Wang; Dongyang Guo; Lichuan Yang; Xiaofen Ma; Lina Zhang; Zi Li
Journal:  Int Urol Nephrol       Date:  2009-11-28       Impact factor: 2.370
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.